Über das Unternehmen
- Firmenname (rechtlich): Shanghai BociMed Pharmaceutical Research Co.,LTD
- Internationaler Name: 上海博志研新药物研究有限公司 (Shanghai BociMed Pharmaceutical Research Co., Ltd.), Shanghai, China
- Marke / Handelsname: BociMed
- Registrierungsland: China
- Adresse: Shanghai
Beschreibung:
Founded in 2007, Shanghai BociMed Pharmaceutical Research Co., LTD (bocimed.com) is a manufacturer and service provider focused on complex APIs and pharmaceutical impurity reference standards, with products including parecoxib sodium, tenofovir alafenamide fumarate, and impurity compounds for tofacitinib, sofosbuvir and tenofovir. Categorized under prophylactic biological products and chiral intermediates, the company offers CRO, CMO and CDMO contract services backed by experienced R&D staff, and distributes globally across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.
Geschäftsaktivitäten
Arzneimittel-Applikationssysteme
Dienstleister
Vertrags- & Outsourcing-Dienstleistungen
Auftragsentwicklungs- und Herstellungsorganisation (CDMO)
Pharmazeutische Chemikalien
HerstellerDienstleister
Biopharmazeutische Produkte
HerstellerDienstleister
Absatzmärkte
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Unsere Produkte & Dienstleistungen
Sell · Biopharmaceutical Products
Certifications
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen